Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: C189- Malignant neoplasm of colon, unspecified Health Condition 3: C399- Malignant neoplasm of lower respiratory tract, part unspecified Health Condition 4: C069- Malignant neoplasm of mouth, unspecified Health Condition 5: C259- Malignant neoplasm of pancreas, unspecified
Conditions
Interventions
Intervention1: None. Only Saliva Samples to be Collected: None. Only Saliva Samples to be Collected
Control Intervention1: None. Only Saliva Samples to be Collected: None. Only Saliva Samples to be Co
Sponsors
Medi Nippon Health Care Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adult subjects aged >=18 years old recently diagnosed with Oral Cancer, Lung Cancer, Pancreatic Cancer, Colorectal Cancer. (All sexes inclusive). 2. Adult subjects aged >=18 years old recently diagnosed with Breast Cancer (females only). 3. Subject/LAR who is willing to give informed consent for participation, able to comprehend and understand the responsibilities during clinical study.
Exclusion criteria
Exclusion criteria: 1. Subjects who are currently undergoing/previously undergoing treatment not limited to chemotherapy, radiation therapy for cancer. 2. Subjects in remission. 3. Subjects with relapse of cancer. 4. Subjects with oral infections not related to diagnosis of cancer, 5. Subjects who are on anti-depressants, anti-psychotics. 6. Any significant medical condition (e.g., significant psychiatric or neurological disorders, active alcohol/drug abuse, etc.), any medical condition that is unstable/poorly controlled or other factor (e.g., planned relocation) that the Investigator felt would interfere with study evaluations and study participation. 7. Subjects who have participated in any clinical study within 3 months from the date of enrolment. 8. Females who are pregnant or lactating or planning to become pregnant during the study period. 9. Subjects who mentally unable to comprehend the responsibilities and adhere to the stipulations of the protocol. 10. Subjects, who in the opinion of the Investigator are not eligible for enrolment in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| There are no outcome measures for this study. This is a study only to collect saliva samples that are to be shipped to JapanTimepoint: There are no outcome measures for this study. This is a study only to collect saliva samples that are to be shipped to Japan | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no outcome measures for this study. This is a study only to collect saliva samples that are to be shipped to JapanTimepoint: There are no outcome measures for this study. This is a study only to collect saliva samples that are to be shipped to Japan | — |
Countries
India
Contacts
Public ContactDr R Senthilkumar
Medi Nippon Health Care Private Limited
Outcome results
None listed